Background: While compression of morbidity has now been studied in multiple cohorts, we hypothesize that centenarians might also have fewer chronic conditions as well. We assume that individuals who die as centenarians have less comorbidities and have a less steep rise of the number of comorbidities over the final years before death compared to those who died as nonagenarians (90-99 years) or octogenarians (80-89 years of age). Methods: This German cohort study used health insurance data. The data contain complete information on diagnoses and health care transactions for the 6 years prior to death. The sample (N = 1,398; 34,735-person calendar quarters) is comprised of three groups of individuals; those who died as centenarians were compared with random samples of individuals who died as nonagenarians or as octogenarians. Community-dwelling and institutionalized individuals were included. Results: One quarter prior to death, individuals who died as centenarians had, on average, 3.3 comorbidities. Octogenarians had 4.6 comorbidities one quarter prior to death. Further, there was a significant time-to-death by age-at-death interaction (B = −.03, p < .001), where centenarians showed a less steep increase in the number of comorbidities than the comparison groups in their last 6 years prior to death.
Multimorbidity is common for most centenarians, though there are large variations between individuals (1-6). Healthy life expectancy is increasing faster than life expectancy (7) and centenarians in their last years of life appear to avoid or delay several common chronic conditions compared to younger cohorts of oldest old (8) . A narrative review of centenarian studies concludes that centenarians cannot be described as healthy; cardiovascular diseases and dementia are the most prevalent conditions (8) . Other common chronic conditions were non-skin cancer, prevalent in 10%-14% of centenarians; diabetes, 6%-13%; and chronic lung diseases, 4%-24% (8) . Data from the Health and Retirement Study have shown that about 23% of centenarians had no major chronic condition, although 45% showed cognitive impairment where disease trajectories differed by sociodemographic factors (9) . Comparing different age groups of centenarians (100-104, 105-109, 110-119 years) and nonagenarians (87-99 years), Andersen and colleagues found that the older cohorts generally had later onsets of conditions such as cancer, cardiovascular disease, and dementia (10) . Although some studies report higher rates of disability in centenarians in comparison with nonagenarians (11) , other findings describe a progressive compression of disability and morbidity toward the end of life in centenarians or that they even outlive the risks for many chronic conditions (11) (12) (13) (14) (15) , which may be due to a select survivor effect (10) . Although the number of comorbidities increases during the course of life, it flattens in centenarians; they may have a lower number of comorbidities compared to younger cohorts of the oldest old and have relatively stable health before a rapid terminal decline (15, 16 ). An analysis of death certificates of centenarians and individuals who died at the age of 70 and older revealed that diseases such as diabetes mellitus and cancer were less often the cause of death in centenarians (12) . Congestive heart failure, atherosclerosis, and neurological causes were more prevalent. Interestingly, unknown and poorly defined causes of death were much more prevalent in centenarians.
Centenarians appear to have a delayed onset of morbidity compared to younger cohorts of oldest old. However, the number of comorbidities and the trajectories of comorbidities in late life in the last years before death have not yet been investigated. To test the hypotheses, we made use of a major health insurance company's electronic health records. The records are population-based and include all insured individuals such as institutionalized individuals as well as individuals without hospital admission, thereby overcoming biases related to self-reporting or selection. Our objective was to investigate the number of comorbidities in the last years prior to death in three groups of individuals who died at a very old age. We compared those who died at 100 years and older (centenarians) with those who died at 90 years and older (nonagenarians), and those who died at 80 years of age and older (octogenarians), hypothesizing that the level of comorbidities would be lower and the trend would be less steep in centenarians compared to the nonagenarians and octogenarians. Further, we expected these differences to persist even after controlling for demographics and health service use.
Methods

Participants and Procedure
This cohort study used routine data on insurants from a major health insurance company in Germany (Knappschaft) for 6 years prior to death. The sample contains a total of N = 1,398 individuals from Germany. All insured individuals who died as centenarians (between January 01, 2015 and December 31, 2015) were selected for the present study (N = 398). In our sample, most centenarians died between the age of 100 and 104 (92.5%). Although 7.5% of the centenarians died at age 105 and older (semi-supercentenarians), there was one single supercentenarian, who died at age 110. To allow comparison across age-at-death groups, two random samples of insured nonagenarians (90-99 years at death; random sample of n = 500 out of N = 9,588) and octogenarians (80-89 years at death; random sample of n = 500 out of N = 19,746) who died in the same time period as the centenarian cohort were selected using SQLServer Management Studio 2008 with Rand(Checksum(NewID())) function. Policyholders at Knappschaft come from a broad range of socioeconomic backgrounds. All German citizens are insured with the compulsory health insurance system, which is based on the principle of solidarity, thus, differences in terms of sociodemographic factors between insurants of different statutory health insurance companies are minor. Nonetheless, the mean age of Knappschaft insurants was 56.3 years of age, whereas the nationwide average is 44.2 years; these differences, though, may vanish in the cohorts of the very old. Data from statutory health insurance companies contain complete information on all diagnoses and health care transactions within the system-i.e., ambulatory, inhospital, and long-term care cases. The local ethics committee approved the study (EA 4/014/17).
Measurements
Age-at-death and time-to-death Age-of-death served as a grouping variable classifying individuals into three groups (died as centenarians, nonagenarians, or octogenarians). Time-to-death served as a time variable covering 25 quarters prior to death, ranging from the first quarter of the seventh year before death to the last fully survived quarter prior to death, resulting in six complete years of time with quarterly structured data available.
Number of comorbidities
The quarterly assessment of comorbidity was based on the Elixhauser comorbidity index according to Quan and colleagues, 2015 , and served as primary outcome in the present study (17) . Thirty health conditions were defined and summed, using established, previously published algorithms (see Supplementary Appendix; 17). Elixhauser comorbidity index was used to predict inhospital mortality, postdischarge all-cause mortality, and health care costs and was used with health care administrative data (18) . Both inpatient and outpatient ICD-10 codes were used to identify each condition; diagnoses labeled "suspected" were excluded. To be included in the index, each diagnosis had to be documented at least twice in individual medical records; in the respective quarter and in the quarter before.
Covariates
Gender, potentially inappropriate medication, hospital stay, longterm care, and two age-related conditions which were not included in the Elixhauser (dementia and rheumatic disease/arthritis) served as covariates in the final model (19) . Physician visits were counted across medical specialties, yet were not considered to be a covariate due to the low variation and resulting convergence problems (>92% had visited a physician at quarter-before-death across age groups and >95% over the entire period of observation). Medications were identified on ATC-level 05. Dispersion of potentially inappropriate medication in older adults was recorded (consensus list-based) (20) . Hospital admissions with a duration of at least 24 hours were also recorded. Using insurance information, institutionalized individuals have been identified and coded as "in long-term care."
Statistical Analyses
To test the increase in the number of comorbidities over the period of 25 calendar quarters prior to death-differential in three groups with age-at-death as centenarian, nonagenarian, or octogenarian-random effects models were specified. In all, 215 (<1%) out of 34,950 possible person-quarters were not included in the data set: this was due to individuals who were new to Knappschaft and did not survive 25 quarters with the company (technically speaking, individuals have been selected from date of death and then followed backward). In total, 34,735 observations across 25 time points were nested in 1,398 individuals. Elixhauser-based number of comorbidities was regressed on time-to-death (linear trend) and time-to-death 2 (quadratic trend) as well as on interaction terms of group allocation and time-to-death (time-to-death × age-at-death 100; time-to-death × age-at-death 90; time-to-death 2 * age-at-death 100; time-to-death 2 × age-at-death 90; age-at-death 80 served as a reference category). Significant time-to-death by group interaction coefficients indicate meaningful differences in trends between the respective age-atdeath groups. Random intercepts (i.e., level) and linear and quadratic trends (i.e., slopes) varied across individuals in the models. In addition to the time-to-death and age-at-death variables, dichotomous time-invariant (i.e., gender [male]) and time-varying covariates (i.e., presence of potentially inappropriate medication, hospital stay, long-term care in each calendar quarter) were included in the model. All dichotomous variables were centered (present = 1; absent = −1). Time-to-death in calendar quarters was coded from −24 to 0 (0 = last fully survived quarter before death). The intercept of the model was interpreted as the individual's number of comorbidities 25 quarters prior to death. All data analyses were conducted using Restricted Maximum Likelihood estimator (REML) with MIXED procedure in SPSS v22 (IBM, 2013). There were no missing data.
Results
The proportion of women was high across the three age-at-death groups and amplified with increasing age (octogenarians = 57.4%; nonagenarians = 72.4%; centenarians = 87.9%). Across all groups, hypertension, congestive heart failure, cardiac arrhythmias, renal failure, and COPD were the most frequent Elixhauser-based comorbidities. For congestive heart failure, those who died as centenarians showed greater proportions of the disease than the other two age groups (see Table 1 ). Hypertension, cardiac arrhythmias, renal failure, and COPD were less frequent in those who died as centenarians compared with those who died at younger age. Concerning age-related comorbidities that were not included in the Elixhauser index, dementia was more frequent in centenarians compared with those who died at 80 (centenarians = 67.9%; octogenarians = 46.8%), whereas for rheumatic disease/ arthritis there were no significant differences across age-at-death groups.
Levels and Trends of Comorbidities by Age-ofDeath Group
The three groups showed small standardized means differences (SMD; for adjusted values, see Table 2 ) in the adjusted model 24 quarters prior to death, with 2.8 comorbidities in individuals who died as nonagenarians or octogenarians and 2.4 in those died as centenarians (SMD 100-90 = 0.2). However, this difference increased one quarter prior to death. At one quarter before death, all age groups differed significantly in their average number of comorbidities; there were on average 3.3 conditions in centenarians, 4.3 conditions in nonagenarians, and 4.6 conditions in octogenarians, corresponding to a medium effect size (SMD 100-80 = 0.6/SMD 100-90 = 0.5; see Figure 1 ). Individuals who died as centenarians had a lower number of comorbidities (B = −.68, p < .001; Table 3 ) one quarter prior to death than the reference group of octogenarians. The nonagenarians also showed a decreased (B = −.21, p = .002) number of comorbidities compared with the octogenarians. Furthermore, there was a significant linear time-to-death by age-at-death group interaction for the centenarians (B = −.03, p < .001) and nonagenarians (B = −.01, p < .001) compared to the octogenarians, where centenarians showed a less steep increase in the number of comorbidities compared to both comparison groups. A very small but significant quadratic trend emerged (quadratic time-to-death by 100 years-at-death group interaction; B = −.00, p = .035). Significant random variance of the linear (B = .04, p < .001) and quadratic trends (B ≤ .001, p < .001) indicate interindividual deviations from the typical trend (for random effects, see Supplementary Appendix).
Discussion
Our aim was to investigate trajectories of the number of comorbidities in the last years prior to death in three groups of individuals who died at very old age using electronic health records for institutionalized and noninstitutionalized individuals. We compared those who died as centenarians with those who died at 90 years and older (nonagenarians) and 80 years and older (octogenarians), hypothesizing that the level of comorbidities would be lower and the trend a In addition to the Elixhauser-based comorbidities, age-related comorbidities (i.e., dementia, rheumatic disease/arthritis) have been reported; for more information, see Supplementary Appendix). The order of the comorbidities is arbitrarily based on the most frequent comorbidities across all of the three subsamples, the ranking varies across subgroups.
would be less steep in centenarians compared to nonagenarians or octogenarians.
Levels and Trends of Comorbidities by Age-ofDeath Group
Individuals who died as centenarians had a lower number of comorbidities one quarter prior to death than the reference group of octogenarians. The nonagenarians age-at-death group also showed fewer comorbidities compared to the octogenarians. Further, individuals who died as centenarians showed a less steep increase of number of comorbidities than the comparison groups. This adds to findings showing a delayed onset and lower levels of several chronic conditions (10,15). Andersen and colleagues showed centenarians aged 100-104 years to have a more rapid decline of physical and mental functioning than nonagenarians, yet they found a later onset of age-related comorbidities in the older compared to the younger centenarians (10) . Analyzing routine health data, Akushevich and colleagues found incidences of Alzheimer's disease, stroke, and heart failure were more common in centenarians compared with people in their 70s, 80s, and 90s, whereas cancers, angina pectoris, diabetes mellitus, asthma, emphysema, arthritis, and goiter showed lower incidence rates in centenarians than in the younger age groups (15) .
We found that all age-at-death groups differed in their average number of comorbidities one quarter before death, with centenarians having, on average, 3.3 comorbidities, which was less than one conditions below the average of the other age-at-death groups. Regarding the number of comorbidities, a study of German centenarians showed the number of conditions was 5.3 on average; 4% had one, 21% had two or three, 38% had four or five, and 37% had more than five health conditions (6) . Factors that may have contributed to the difference in the number of condition from the present study may be sample composition and comorbidity score algorithm used. In our data, across all age-at-death groups, hypertension, congestive heart failure, cardiac arrhythmias, renal failure, and COPD were the most frequent Elixhauser-based comorbidities. Centenarians showed greater proportions of congestive heart failure than the other two groups, but not for any other diseases. The other conditions were less frequent in those who died as centenarians compared with those who died as nonagenarians or octogenarians. Regarding age-related comorbidities that were not included in the Elixhauser index, dementia was more frequent in individuals who died as centenarians (67.9%) compared with those died as octogenarians, whereas for rheumatic disease/arthritis the age groups showed comparable proportions. Recent routine data from another sample of centenarians from Berlin support this finding; the most frequent chronic conditions were dementia and rheumatic disease/ arthritis, at 66% and 64%, respectively (21) . In noninstitutionalized Canadian centenarians, 17% had more than two conditions; dementia (58%), arthritis (54.5%), congestive heart failure (35%), and COPD (27%) were the most frequent (3). Comparable results have been found in other countries (1,2,4-6,22 ).
Limitations
Several limitations of our study need to be mentioned. First, standard data from a main statutory health insurance company may be comprehensive; cover most diagnoses related to health service use; and overcome problems of self-reporting bias, selective case drop out, or Figure 1 . Predicted trends of the number of Elixhauser-based comorbidities over time-to-death by age group. The thin gray lines represent the individual predicted trajectories of 100 randomly selected cases. The black thick lines represent average predicted trajectories. The solid black line is the estimated average number of comorbidities in centenarians with age-atdeath over 100 years; the dashed line is age-at-death over 90 years group (nonagenarians); the dotted black line is age-at-death over 80 years group (octogenarians). missing data; these data are limited to routinely collected information and conditions such as dementia may be underdiagnosed. Second, our sample is not necessarily representative of the German population, though we analyzed data of a large health insurance company with insured individuals across the country and of a broad range of socioeconomic backgrounds. Third, to improve the validity of diagnoses data, we only included diagnoses that were coded at least twice; therefore, it is also likely that some correct diagnoses were lost. Although health insurance data tend to contain valid diagnoses from physicians, we were not able to prove the validity of the diagnoses. Fourth, as we compared three distinct birth cohorts, a cohort effect may be plausible (23) . Fifth, we were not able to investigate semi-supercentenarians (105-109 years old) or supercentenarians (110 years and older) as separate cohorts, thus, trajectories may look different in these cohorts at the limit of human life span (10, 24, 25) . Sixth, although we adjusted our analyses for the presence of hospital stay and long-term care, that centenarians were less likely to receive treatment for health problems than nonagenarians and octogenarians cannot be ruled out. As the number of physician visits was very high across age groups and all age groups can be considered as advanced age, there may still be differences in visits to specialists, diagnostics, and treatment.
Conclusions
The number of comorbidities does not appear to increase linearly in the last years before death but flattens as it approaches very old age, i.e., in centenarians. The compression of morbidity hypothesis suggests a delayed onset of morbidity when individuals approach the limits of life span. However, our findings indicate that centenarians have fewer comorbidities than their slightly younger counterparts without completely escaping multimorbidity (10) . The lower level (intercept at starting point) of the comorbidity trajectory in centenarians may also be explained by a selectivity effect, where individuals with a higher comorbidity burden do not live to be 100 (26) . Both the less steep trajectory and the lower starting point has implications for the morbidity burden and the burden on the health care system. The number of conditions and thus the health care costs appears to stabilize in centenarians rather than progressively increase (27) . Nevertheless, there is still a substantial morbidity burden in centenarians, with dementia and arthritis among the most common conditions. Despite the presence of multimorbidity in our data, functional limitations and disability may still be compressed to the very end of the lifespan, at least in a minority of centenarians (10, 28, 29) . Today, reaching the age of 100 years is not as exceptional as it has been in the past. Although there might be challenges associated with an increasing number of centenarians in terms of the total resources that they require over time, they may cost less because they appear to live with a lower number of conditions, compared to octogenarian and nonagenarians. Solutions for health care professionals and the health care system may include training more geriatricians and specialized GPs. Moreover, as dementia is highly prevalent in centenarians, there should be a focus on prevention, treatment, and care. Future studies should also inquire further into lifestyle factors, health care use, onset of conditions, and physical resilience in relation to comorbidity trajectories in centenarians (30) (31) (32) .
We investigated comorbidity trajectories in advanced age and found that centenarians differ in their comorbidity trends during the 6 years before death compared to individuals who died as nonagenarians or octogenarians. Centenarians have both fewer comorbidities and a less steep increase in the number of comorbidities as they approach death. Future investigations may focus on isolating factors that contribute to this profile. 
Supplementary Material
Supplementary data is available at Journals of Gerontology, Series A: Biological Sciences and Medical Sciences online.
Funding
This work was supported by Knappschaft, Germany.
